Barry Mick
Pharmaceutical Sales Executive with a History Success in Driving the Sales of New and Established Brands
- Role
- Executive Sales Representative at Eli Lilly and Company
- Location
- Knoxville, TN, US
- LinkedIn followers
- 500 followers
About Barry Mick
Driven sales, business development and account management leader with a proven track record of selling products, brands and services that increase market share and revenue. Recognized for leading regional, territory and sales representatives to achieve the highest sales performance rankings and growth. Selected highlights from my career include:Ranked in the top 5% Dashboard performance in 2011 at Eli Lilly & Company; achieved top performance ranking (1st out of 38 teams) as Senior Professional Representative at Merck & Company.Drove the successful launch of two multi-billion dollar cardiovascular brands; improved top-share performance of portfolio brands to exceed sales quota during the initial launch phase.Developed data analysis tools (MSK Scorecard/Weekly Brand Trackers) that were utilized companywide at Eli Lilly & Company; conducted market analysis for two key portfolio brands.Received numerous sales awards including Eli Lilly’s Territory Turn-Around Award and Merck’s USHH Distinguished Achievement Award, Director’s Award, Rookie of the Year and Regional Top Team Award.
Experience
Executive Sales Representative
Feb 2009 — Present · Knoxville, TN, US
Executive Sales Representative / Senior Sales Representative - ELI LILLY & COMPANY 2009-Drove the pharmaceutical sales and business development of multiple product brands across multiple territories and therapeutic classes. Secured and closed key accounts and customers contributing to 80% of business; included capture of competitive brand market share by top prescribers.Accelerated launch in diabetes market of two SGLT2i and GLP1 blockbuster brands in Knoxville market (2015-)Achieved a top 50% Dashboard performance in 20••••13 despite changing territories mid-year. Achieved to 5% National Ranking for portfolio performance.Accomplished top 15% Dashboard performance in 2010 for growing assigned portfolio market share faster than average; exceed plan in two of three brands.Grew market share attainment for two new pharmaceuticals (Zyprexa and Strattera) faster than benchmarks; performed at 113% of quota on Zyprexa share in 2009.Reached 100% quota on Strattera product by increasing current market share.
Education
Cleveland State University
MPA, Public Administration
1991 — 1993
Hiram College
Bachelor of Arts (BA), Political Science and Government
1987 — 1991
Skills
- Rheumatology
- Product Launch
- Pharmaceutics
- Sales
- Selling Skills
- New Business Generation
- Ob/Gyn
- Management
- Osteoporosis
- Cardiology
- Business Planning
- Strategic Planning
- Psychiatry
- Market Access
- Sales Operations
- Pulmonology
- Crm
- Customer Centric Solutions
- Pharmaceutical Industry
- Sales Effectiveness
- Endocrinology
- Dermatology
- Hunter
- B2b
- Urology
- Opportunity Assessment
- Healthcare
- Neurology
- Business Growth Strategies
- Sales Presentations
- Managed Care
- Trend Analysis
- Profit Margins
- Direct Sales
- Superior Work Ethic
- Market Planning
- Pharmaceutical Sales
- Primary Care
- Customer Service Management
- Therapeutic Areas
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.